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Summary
Vitamin A, E, C and 86 .status was studied in -30
patients with myocardial infarction and in 19 age-
and sex~matched patients after elective surgery or
. trauma. Plasma levels of the four vitamins studied
were low, remained low or decreased transiently in
both groups of patients during the acute catabolic
response phase, and began to return to normal after
the third day from the start of the catabolic response.
These changes in"plasma levels are therefore neither
of any special pathophysiological importance in nor
specific to myocardial infarction.
S Air Med J 1987; 71: 561-563.
The original work of Rinehart and Greenberg l indicated that
vitamin B6 deficiency may be a contributory factor in the
development of atherosclerosis. Since then, this role for vitamin
B6 has been a subject of controversy.2.3 This controversy has
recently been revived by the documentation of lower than
normal plasma levels of pyridoxal-5' -phosphate (PLP), the
active co-enzyme form of vitamin B6, early in the course of
myocardial infarction (MI).4
It has since been shown5 and confirmed6 that ischaemic
heart disease (IHD) bears no relationship to vitamin B6 status.
Furthermore, the lower than normal plasma PLP levels after
MI have been confirmed, and it has been proposed6 that the
observed low levels may be due to the acute starvation attendant
on the acute phase of MI. Certainly plasma PLP levels
decrease by approximately 43% in normal subjects after pro-
longed fasting. 6
It therefore appears that plasma PLP levels are lower than
normal during the acute phase of MI. These low plasma levels
may represent a transient6 and relative state of deficiency or,
alternatively and more likely, may be due to the catabolic
response attendant on MI. Should this be the case, plasma
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PLP levels in MI patients ought to be compared with those of
catabolic patients with conditions other than MI rather than
with those in normal subjects.
In view of the possible role vitamin C, A and E may play in
IHD via their proposed protective function against radical-
mediated damage/' we have studied the status of these vita-
mins together with PLP' in patients with MI and control
patients in a catabolic state.
Patients and methods
All 30 patients investigated consecutively (mean age 56,3 ± 12
years; range 27 -73 years) had acute MI on clinical, ECG and
biochemical grounds. Eight had had a previous infarction, 18 had
angina for a minimum of 3 years preceding the MI, and in 2 the
MI was complicated by an incomplete right bundle-branch block.
Blood samples were drawn on admission and at 8, 12, 24, 48, 72
and 144 hours after the onset of chest pain. Wherever possible,
blood samples were also drawn at 6 weeks' and 3 months'
follow-up.
The 19 age- and sex-matched patients (mean age 51,6 ± 14,8
years; range 30 - 75 years) who served as controls had suffered
various fractures or attended Tygerberg Hospital for elective
surgery. Blood sampling was done as for the MI patients, except
that a pre-operative sample was taken whenever possible. The
admission sample in these .patients was taken immediately post-
operatively or, in the case of the trauma patients, on arrival at the
hospital. None of the MI patients or the controls studied was
taking any vitamin supplements on admission or during the study.
Blood analysis included electrolyte, urea, creatinine, albumin,
creatine kinase (CK), lactate dehydrogenase (LDH) and aspartate
aminotransferase (AST) levels, as well as a full blood and differen-
tial count.
Plasma was used for the analysis of vitamins A9, E9, 0°, and
B6 11, as well as totallipids (Boehringer kit), retinol-binding protein(RBP) (Partigen plate method; Hoechst Pharmaceuticals), and C-
reactive protein (CRP).12 The blood for vitamin analysis was
processed immediately in all cases, except for overnight samples
which were kept at 4°C in the dark and processed within a
maximum of 12 hours. Plasma was stored at -20°C and all
analyses were completed within a maximum of 7 days. Stability
studies under these conditions revealed no sample deterioration.
Results
Plasma CRP, an indicator of acute-phase response, gradually and
significantly increased (P < 0,001), reaching a peak on the 2nd
postoperative and 3rd post-MI day respectively in the control and
MI groups before returning to normal (Fig. I).
Plasma vitamin A levels (Fig. 2) were significantly lower (P <
0,005) in the control group on admission and remained lower until
the 6th day of observation when the difference between the two
groups was no longer significant. In both the control and the MI
group, however, plasma levels decreased significantly (P < 0,005)
during the first 3 days of observation. Concomitantly, plasma RBP
decreased significantly in MI patients (P < 0,001) from 4,96 ± 0,2
mg/I on admission to 3,34 ± 0,26 mg/I on day 3 before rising
significantly (P < 0,001) to 5,14 ± 0,26 mg/I in the 6th week of
observation. A similar decrease was seen in controls (on admission
4,04 ± 0,33 mg/I; 3rd day post-trauma/surgery 2,84 ± 0,35 mg/I;
P< 0,02).
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Fjg. 1. The plasma CRP levels in post-MI and post-surgical/post-
trauma patients who served as controls (mean ± 1 SEM).
Pf.£-OP ADMISSION 8HRS 12HRS 24HRS 20AYS 3DI\l'S 6DAYS 6WEEKS 3foJ()NTHS
TIMEl HRStOAYS)
.PATlENTS
OCONTROlS
I···..... /..f....·i1..·..+-·.. ./
- ·--r-·····}---..l··..1"
PFEOP ADMISSION BHRS t2HRS 24HRS 20AYS 3DAYS 6Q.O.VS 6V\oEEKS 3t'AONTHS
TlME{ HAS/DAYS)
20
ID
~ 16
=16
~
>
<
"~
<
~ 12
1·
--1-----+1\
1+/[z 60~>
30
50
90
<
"~
<
~ 40
~ 80g
i 70
.. PATIENTS
OCQNTROLS
~;;;
E 1.0
Z 0.8
~
> 0.6
~
~
<
~ 0.4
0.2
PRE-OP ADMISSION 8H'lS 12HRS ;?!4!-FlS 2DAYS 30AYS ID'oYS 6V'JEEKS 3t-JO,lTHS
TIME (HAS/DAYS)
.. PArlENTS
o CONTROLS
T
T ./1·····-1
..=1'.....-1/
r·····1·_···1· ....-1...··l ·
PRE-QP ADMISSION SHAS 12HRS 24HRS 20AYS 3DA'IS 6DAYS 6WEEKS 3~
TIME I HRS/OAYSI
Fig. 3. Plasma vitamin E (bottom) and totallipids (top) in post-MI
and post-surgical/post-trauma patients who served as controls
(mean ± 1 SEM).
the period of observation (Fig. 3). It can be seen that both groups
of patients showed a transient and significant decrease (P < 0,01)
in plasma levels during the first 3 days post-MIIpost-trauma and
that levels began to rise again to those on admission from the 6th
day onwards.
Plasma albumin levels, although significantly lower (P < 0,01)
in the control group, showed a progressive decrease in both
groups of patients and were significantly lower (P < 0,001) on the
6th day (Fig. 4). Plasma PLP levels (Fig. 4) were similar in both
groups of patients and began rising to above admission levels from
the 3rd day onwards, being significantly higher (P < 0,025) than
admission values in the MI group at 6 weeks and 3 months
after MI.
Fig. 2. Plasma vitamin A (top) and C (bottom) values in post-MI
and post-surgical/post-trauma patients who served as controls
(mean ± 1 SEM).
Vitamin C levels (Fig. 2) were consistently and significantly
lower (P < 0,025) in the MI group than in controls. In the laner
group a significant decrease (P < 0,05) was present between the
pre- and postoperative values. Although some patients in both
groups had plasma vitamin C levels below the lower limit of
normal for this laboratory (0,25 mg/IOO ml), all patients had
values within the normal range by the 6th day of observation. The
levels of vitamin C were significantly higher at 6 weeks and 3
months post-MI than any of the values during the first 6 days
after MI.
Plasma vitamin E and total lipid levels were significantly higher
(P < 0,001) in the MI group than in the control group throughout
Discussion
This study has shown that low plasma PLP levels after MI are
not in any way of special pathophysiological importance since
levels of other vitamins such as vitamin C, and of other
nutriems such as magnesium 13 also appear to be low in these
patients. Furthermore, this study has shown that the levels of
the four vitamins studied are low, remain low or decrease
transiemly during the acute catabolic response to injury, irres-
pective of aetiology, and begin to return to normal after the
3rd day from the start of the response to injury. .
It has been argued 1-7 that vitamin B6 deficiency, especially
marginal chronic deficiency, may play a role in the pathogenesis
of IHD. Evidence put forward for such a role includes, among
others, the catalytic function .of the vitamin in the methionine-
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nutrients. It is for this reason that no one single nutrient
should be afforded special status in anyone given pathogenetic
process, unless such special status can be proved.
In conclusion, this study shows that the low or transiently
decreased plasma vitamin levels in MI patients are not indica-
tive of any special pathogenetic relationship between vitamin
status and MI but rather reflect a response to the catabolic
process induced by injury.
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homocysteine metabolism,14 the tendency to increased thrombus
formation,15 the catalytic role in the cross-linking of collagen, 16
and its possible role in cholesterol metabolism. 17 While this
may be so, and with the possible exception of the involvement
of vitamin B6 in thrombus formation, none of the other
evidence applies exclusively to vitamin B6. Abnormal homocys-
teine accumulation in body fluids can occur not only by
genetic block or block from relative B6 deficiency in the
conversion of homocysteine to cystathionine (cystathionine
synthetase deficiency),18 but also by inhibition of the conversion
pathway of homocysteine to methionine, which requires methy-
lated derivatives of both vitamin B12 and folic acid,18,19 the
latter being one of the commonest deficiencies known. 2o
Vitamin B6 is important in the maintenance of the activity of
lysyl oxidase,16 an enzyme involved in the normal cross-linking
of collagen, but so is copper,21 and not only cross-link defects
are seen in copper-deficient animals22,23 but also elevated
plasma cholesterol levels in both animals24,25 and man,26 not to
mention the interaction of zinc and copper and their possible
role in IHD.27
Finally, vitamin B6 may have a role to play in cholesterol
metabolism,17 but so has vitamin C in perhaps an equal or
more important way. Vitamin C deficiency is known to interfere
directly with the metabolism of the vascular wall by impairing
collagen and glycosaminoglycan metabolism28 to induce hyper-
cholesterolaemia by reducing the activity of the cholesterol 7ex-
hydroxylation system,29 and to induce hypertriglyceridaemia.30
Any controversy may have significant negative implications.
The controversy regarding the role of vitamin B6 deficiency in
the pathogenesis of IHD has certainly caused confusion. It
does, however, highlight the importance of nutrition as a
whole and the delicate, and often ignored, interaction of
Fig. 4. Serum albumin (top) and plasma PLP (bottom) in post-MI
and post-surgical/post-trauma patients who served as controls
(mean ± 1 SEM).
